← Back
$ARQT All transactions

Arcutis Biotherapeutics, Inc.

A

$ Value

$0

Shares

60,000

Price

$0

Filed

May 7

Insider

Name

Vairavan Latha

Title

SVP Chief Financial Officer

CIK

0002065881

Roles

Officer

Transaction Details

Transaction Date

2025-05-06

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

60,000

Footnotes

Represents Restricted Stock Units ("RSUs") that will vest as to 25% of the RSUs on each annual anniversary of May 1, 2025 (the "Vesting Commencement Date"), beginning on May 1, 2026, subject to the Reporting Person's continued service through the vesting date. | The options will vest and become exercisable as to 1/48th of the shares on each monthly anniversary of May 6, 2025 (the "Vesting Commencement Date"), subject to the Reporting Person's continued service through the applicable vesting date.

Filing Info

Accession No.

0002065881-25-000005

Form Type

4

Issuer CIK

0001787306

Vairavan Latha's History

Date Ticker Type Value
2026-03-02 ARQT $70K
2026-03-02 ARQT $2K
2026-02-27 ARQT A $0
2026-02-27 ARQT A $0
2026-02-02 ARQT $34K
2025-11-03 ARQT $2K
2025-08-04 ARQT $1K
2025-05-06 ARQT A $0
2025-05-06 ARQT A $0

Other Insiders at ARQT (90d)

Insider Bought Sold Last
Leonard Keith R $997K 2026-03-02
Burnett Patrick
See Remarks
$505K 2026-03-02
Matsuda Masaru
See Remarks
$1.3M 2026-03-02
Welgus Howard G. $746K 2026-04-01
Watanabe Todd
See Remarks
$1.4M 2026-03-02
Edwards Larry Todd
See Remarks
$145K 2026-03-02
Vairavan Latha
SVP Chief Financial Officer
$106K 2026-03-02